表紙
市場調查報告書

全球非處方藥市場:止痛藥銷售的增長為市場增長做出了貢獻

Global Market Study on OTC Consumer Healthcare: Increasing Sales of Analgesics Contributing to Market Growth

出版商 Persistence Market Research 商品編碼 954052
出版日期 內容資訊 英文 300 Pages
商品交期: 2-3個工作天內
價格
全球非處方藥市場:止痛藥銷售的增長為市場增長做出了貢獻 Global Market Study on OTC Consumer Healthcare: Increasing Sales of Analgesics Contributing to Market Growth
出版日期: 2020年07月10日內容資訊: 英文 300 Pages
簡介

該報告調查和分析了全球OTC藥品市場,當前市場趨勢,主要市場機會,COVID-19的影響,需求分析和預測,按細分市場/區域的市場分析和預測。以及主要公司的資料。

目錄

第1章執行摘要

第2章市場概述

  • 市場分類
  • 市場定義

第3章主要市場趨勢

  • 影響市場的主要趨勢
    • 由於新品牌的出現,競爭加劇
    • 改用自我療法
    • 止痛藥:明年再次稱霸市場
    • 增加對藥物和補品中天然成分的偏愛
    • 零售條件的變化
    • 影響生活方式的全球化
    • 其他
  • 產品創新趨勢
  • 場外醫療行業的發展
  • 成功主題
    • 新產品創新-臨床證據支持宣傳
    • 有效營銷-主要活性成分

第4章市場風險和機遇

  • 相關風險
    • 與監管狀態有關的風險
    • 標準和認證風險
  • 市場機會
    • 現有產品線中的利基市場
    • 新產品類別的機會
    • 現有市場中的潛在機會
  • 主要法規和行業標準
    • 國家法規
    • 進口限制

Covid-19的第5章市場影響力

  • Covid-19:當前狀態
  • 各國封鎖的影響
  • Covid-19危機經濟影響方案
  • 受影響的行業:冠狀病毒在世界各地爆發
  • 受影響最嚴重的部門的預計復甦
  • 冠狀病毒對工作世界的影響
  • Covid-19對製造業的影響
  • 2020年製造業和採購經理指數
  • Covid-19對全球供應鏈的影響
  • Covid-19大流行期間的計劃和管理
  • 企業領導者應注意的未來建議

第6章Covid-19對OTC藥品市場的影響

  • Covid-19的行業影響
  • 2020年Covid-19的影響和非處方藥市場的國家價值
  • 2020年第一季度至第四季度大流行期間的Covid-19 OTC藥品銷售預測
  • Covid-19之前的市場預測和Covid-19以後的市場預測

第7章Covid-19對零售業的影響

  • 冠狀病毒影響矩陣
  • 在大多數領域,銷售額都急劇增長:所有國家/地區的紙張,家庭護理和個人護理產品激增
  • 全球消費者影響細分支出贏/虧
  • 消費者信心反映出對病毒和衰退的恐懼

第8章全球OTC藥品市場需求分析和預測

  • 過去的市場分析
  • 當前和未來市場預測
  • 同比增長趨勢分析

第9章全球OTC藥品市場價格分析

  • 區域價格分析:按產品
  • 價格分割
    • 製造商級別的價格
    • 分銷商價格
  • 世界平均價格分析基準

第10章全球OTC藥品市場需求分析和預測

  • 過去的市場分析
  • 當前和未來市場預測
    • 同比增長趨勢分析

第11章市場背景

  • 場外製藥行業
    • 處方和非處方藥消費量分析
    • 行業領先的全球公司
    • 人均OTC產品支出
    • 非處方藥在全球市場的滲透率
  • 宏觀經濟因素
    • 全球GDP增長前景
    • GDP增長率分析
    • 全球行業增加值
    • 全球電子商務行業前景
    • 資本投資前景
    • 城鎮化增長前景
    • 全球醫療行業前景
  • 產業價值與供應鏈分析
    • 每個銷售點的利潤分析
    • 主要市場參與者及其角色列表
  • 預測變量的相關性和影響
    • 頂級公司的增長歷史
    • 全球製藥行業展望
    • 全球消費者物價指數展望
    • 製造部門的總增加值
    • 全球零售銷售前景
  • 消費者心理分析
    • 消費者喜歡的特定品牌以及原因
    • 影響市場行為的因素 供應商首選廣告風格
    • 與市場供應商有關的主要問題
    • 其他
  • PTC LE對非處方藥市場的分析
  • 場外藥品市場投資可行性表
  • 波特的五力分析
  • 產品開發與發佈
  • 市場動態
    • 生長因子
    • 抑制因子
    • 市場機會分析

第12章按產品分列的全球OTC藥品市場分析和預測

  • 簡介/主要發現
  • 過去的市場和按產品分析
  • 當前和未來的市場以及按產品分析/預測
    • 非處方藥
    • 膳食補充劑
  • 按產品劃分的市場吸引力分析

第13章最終用戶對全球OTC藥品市場的分析和預測

  • 簡介/主要發現
  • 過去的市場和最終用戶的分析
  • 當前和未來市場,最終用戶的分析和預測
    • 12至19歲
    • 女人
    • 兒童
  • 最終用戶的市場吸引力分析

第14章按類型劃分的全球OTC藥品市場分析和預測

  • 簡介/主要發現
  • 過去的市場和分析:按表格
  • 當前和未來市場,分析和預測:按類型
    • 平板電腦
    • 粉末
    • 液體
    • 其他
  • 按類型劃分的市場吸引力分析

第15章按銷售渠道對全球OTC藥品市場進行分析和預測

  • 簡介/主要發現
  • 過去的市場和按銷售渠道分析
  • 當前和未來市場以及按銷售渠道進行的分析/預測
    • 批發商和分銷商
    • 藥房或藥店
    • 專賣店
    • 在線零售商
    • 大型超市
    • 其他銷售渠道
  • 按銷售渠道劃分的市場吸引力分析

第16章按地區分列的全球OTC藥品市場分析和預測

  • 簡介
  • 過去的市場和按地區分析
  • 當前市場和按地區分析/預測
    • 北美
    • 歐洲
    • 中東/非洲(MEA)
    • 東亞
    • 南亞
    • 大洋洲
    • 拉丁美洲
  • 按地區劃分的市場吸引力分析

第17章北美市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第18章拉丁美洲市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第19章歐洲市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第20章南亞市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第21章東亞市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第22章大洋洲市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第23章中東和非洲市場分析和預測

  • 簡介
  • 價格分析
  • 通過市場分類方法分析過去的市場趨勢
  • 按市場分類的市場和規模預測
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場吸引力分析
    • 按國家
    • 按產品
    • 最終用戶
    • 通過表格
    • 通過銷售渠道
  • 市場趨勢
  • 主要市場參與者-實力圖
  • 生長因子和約束影響分析

第24章市場結構分析

  • 市場分析:按公司層次劃分(非處方藥)
  • 市場集中度
  • 頂級公司的市場份額分析
  • 市場佔有率分析
    • 公司區域足跡
    • 按公司劃分的產品足跡
    • 按公司劃分的渠道足跡

第25章競爭分析

  • 競爭性儀表板
  • 價格分析:按競爭對手
  • 競爭基準
  • 衝突
    • Sun Pharmaceutical Industries Limited
    • Glenmark Pharmaceuticals Ltd.
    • Johnson & Johnson Private Ltd, Pfizer, Inc.
    • American Health Corporation
    • Abbott Laboratories Inc.
    • GlaxoSmithKline plc
    • Sanofi S.A.
    • Piramal Enterprises Ltd.
    • Boehringer Ingelheim GmbH
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • Ipsen SA, BASF SE
    • Koninklijke DSM N.V.
    • Reckitt Benckiser LLC.
    • Lonza Group Ltd.
    • 其他

第26章先決條件和縮寫

第27章:調查方法

目錄

Scope of the Report

Persistence Market Research (PMR) has recently published a new research analysis on the OTC consumer healthcare market for the assessment period of 2020-2030. The research study offers a close look at the evolving aspects of the OTC consumer healthcare market and the dynamics impacting market growth. It also focuses on key developments that have made a mark in the OTC consumer healthcare market, and what other developments are on the cards. The report talks about various macro- and micro-economic factors responsible for giving an in-depth analysis of the market.

The research study on the OTC consumer healthcare market extensively focuses on key trends shaping its growth. In addition, opportunity analysis on OTC consumer healthcare underline untapped corners for aspiring players to make a note of. In addition, this research study on the OTC consumer healthcare market also offers a panoramic view of the incremental opportunity, which can further help readers make well-informed decisions.

Several stakeholders in the OTC consumer healthcare market can rely on the data offered in this research study and delve into pragmatic decision-making. Moreover, information offered in the report also can help new market entrants expand their bases in the OTC consumer healthcare market.

The report elaborates on both, historical and current trends molding the growth of the OTC consumer healthcare market. The performance of the OTC consumer healthcare market has been drawn and analyzed in ways that the lucrative side of the market is evident to readers. Competitive landscape provided in the report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.

The OTC consumer healthcare market research report includes a competitive landscape that provides a dashboard view of key competitors operating in the market. Some of the market players profiled in this section include Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Ltd., Johnson & Johnson Private Ltd, Pfizer, Inc., American Health Corporation, Abbott Laboratories Inc, GlaxoSmithKline plc, Ipsen SA, Sanofi S.A., Bayer AG, Piramal Enterprises Ltd., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, BASF SE, Koninklijke DSM N.V., Reckitt Benckiser LLC, and Lonza Group Ltd.

Key Questions Answered:

The research study offers inclusive insights about the growth of the OTC consumer healthcare market in the most comprehensible manner for the better understanding of readers. Key insights offered in this report answer some of the salient questions that assist stakeholders in gauging all emerging possibilities.

  • How has rapidly changing consumer perspective acted as a major growth engine for the OTC consumer healthcare market?
  • How does e-Commerce boost OTC consumer healthcare market growth?
  • Do omni-channel concepts help companies grow in the global OTC consumer healthcare market?
  • What are the key trends that are constantly shaping the growth of the OTC consumer healthcare market?
  • Which are the prominent regions offering plentiful opportunities for the market?
  • What are the differential strategies adopted by key players to command a significant chunk of the global market share?

Research Methodology:

A unique and promising research methodology forms the base of the OTC consumer healthcare market report for the forecast period. The report has been prepared after comprehensive analysis of market happenings, and riveting insights have been compiled meticulously. The research methodology for the OTC consumer healthcare market is a two-step process, comprising primary and secondary research. Key stakeholders such as OTC consumer healthcare product suppliers and manufacturers, and experts of several designations, including executive vice presidents, directors, service engineers, technical advisors, GM marketing professionals, and sales professionals have been interviewed.

Secondary sources referred to acquire report findings include investor presentations of manufacturers, healthcare industry reports, Consumer Healthcare Products Association, and many other credible sources.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Key Statistics
  • 1.3. Summary of Key Findings
  • 1.4. Product Evolution Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
    • 3.1.1. The Entrance of New Brands Aggravates Competition
    • 3.1.2. People have now switched to self-treatment
    • 3.1.3. Analgesics to Continue Dominating the Market in the Coming Years
    • 3.1.4. Growing Preferences for Natural Medicinal Products and Supplements
    • 3.1.5. Changing Retail landscape
    • 3.1.6. Globalization Impacting Lifestyles
    • 3.1.7. Others
  • 3.2. Product Innovation Trends
  • 3.3. Evolution of OTC Healthcare Industry
  • 3.4. Winning Themes
    • 3.4.1. New Product Innovations- Clinical Evidence Supporting Their Claims
    • 3.4.2. Effective Marketing- Key Active Ingredients

4. Risk and Opportunities in The Market

  • 4.1. Associated Risk
    • 4.1.1. Regulatory Landscape Associated Risk
    • 4.1.2. Standard & Certification Risk
  • 4.2. Opportunities
    • 4.2.1. Niche Within The Existing Product Line
    • 4.2.2. Opportunities In New Product Categories
    • 4.2.3. Latent Opportunities In Established Market
  • 4.3. Key Regulations & Industrial Standards
    • 4.3.1. Rules & Regulations By Countries
    • 4.3.2. Regulations With Respect To Imports

5. Impact of Covid-19 on The Market

  • 5.1. Covid-19 The Situation Now
  • 5.2. The Effects of National Lockdown in Various Countries
  • 5.3. Scenarios For The Economic Impact of The Covid-19 Crisis
  • 5.4. Industries Affected By Coronavirus Outbreak Worldwide
  • 5.5. Projected Recovery for Hardest Hit Sectors
  • 5.6. Coronavirus Impact on The World of Work
  • 5.7. Impact of Covid-19 on Manufacturing Industry
  • 5.8. Manufacturing Purchasing Managers Index, 2020
  • 5.9. Impact of Covid-19 on Supply Chain Worldwide
  • 5.10. Planning & Managing During Covid-19 Pandemic
  • 5.11. Upcoming Pointers Business Leaders Should Focus On

6. Impact of Covid-19 on The OTC Consumer Healthcare Market

  • 6.1. Impact of Covid-19 on the Industry
  • 6.2. Covid-19 Impact v/s Value of OTC Consumer Healthcare Market, by Country 2020
  • 6.3. OTC Consumer Healthcare Sales Projection, Q1-Q4 2020 During Covid-19 Pandemic
  • 6.4. Pre Covid-19 Market Forecast v/s Post covid-19 Market Forecast

7. Covid-19 Impact on Retail Industry

  • 7.1. Coronavirus Impact Matrix
  • 7.2. Sales Increased Dramatically Across Most Categories; Paper Products, Home Care, and Personal Care Products Spiked in all Countries
  • 7.3. Global Consumers Impact - Winning and Losing Segment Spending
  • 7.4. Consumer Sentiment Reflects Fear of the Virus and of Recession

8. Global OTC Consumer Healthcare Market Demand Analysis 2015-2019 and Forecast, 2020-2030

  • 8.1. Historical Market Volume (Mn Tons) Analysis, 2015-2019
  • 8.2. Current and Future Market Volume (Mn Tons) Projections, 2020-2030
  • 8.3. Y-o-Y Growth Trend Analysis

9. Global OTC Consumer Healthcare Market - Pricing Analysis

  • 9.1. Regional Pricing Analysis By Product
  • 9.2. Pricing Break-up
    • 9.2.1. Manufacturer Level Pricing
    • 9.2.2. Distributor Level Pricing
  • 9.3. Global Average Pricing Analysis Benchmark

10. Global OTC Consumer Healthcare Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 10.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 10.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 10.2.1. Y-o-Y Growth Trend Analysis
    • 10.2.2. Absolute $ Opportunity Analysis

11. Market Background

  • 11.1. OTC Consumer Healthcare Products Industry
    • 11.1.1. Prescribed vs OTC Healthcare Products Consumption Analysis
    • 11.1.2. Top Global Player In Industry
    • 11.1.3. Per Capita Spending on OTC Products
    • 11.1.4. Penetration of OTC Consumer Healthcare Products in the Global Market
  • 11.2. Macro-Economic Factors
    • 11.2.1. Global GDP Growth Outlook
    • 11.2.2. GDP Growth Rate Analysis
    • 11.2.3. Global Industry Value Added
    • 11.2.4. Global E-Commerce Industry Outlook
    • 11.2.5. Per Capital Spending Outlook
    • 11.2.6. Urbanization Growth Outlook
    • 11.2.7. Global Healthcare Industry Outlook
  • 11.3. Industry Value and Supply Chain Analysis
    • 11.3.1. Profit Margin Analysis at each sales point
    • 11.3.2. List & role of key participants
      • 11.3.2.1. Manufacturers
      • 11.3.2.2. Distributors/Retailers
      • 11.3.2.3. List of Private Label Brands
  • 11.4. Forecast Factors - Relevance & Impact
    • 11.4.1. Top Companies Historical Growth
    • 11.4.2. Global Pharmaceutical Industry Outlook
    • 11.4.3. Global Consumer Price Index Outlook
    • 11.4.4. Manufacturing Sector Gross Value Added
    • 11.4.5. Global Retail Sales Outlook
  • 11.5. Consumer Sentiment Analysis
    • 11.5.1. Which Specific Brand Is Preferred By The Consumers And Why?
    • 11.5.2. Factors Influencing Market Behaviour
    • 11.5.3. Which Mode Of Advertisement Does Vendors Prefer?
    • 11.5.4. What Are The Key Challenges Associated With The Market Suppliers?
    • 11.5.5. Others
  • 11.6. PESTLE Analysis of OTC Consumer Healthcare Market
  • 11.7. Investment Feasibility Matrix of OTC Consumer Healthcare Market
  • 11.8. Porter's Five Force
  • 11.9. Product Development and Launches
  • 11.10. Market Dynamics
    • 11.10.1. Drivers
    • 11.10.2. Restraints
    • 11.10.3. Opportunity Analysis

12. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Product

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Product, 2015 - 2019
  • 12.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Product, 2020 - 2030
    • 12.3.1. OTC Pharmaceutical
      • 12.3.1.1. Eye Care
      • 12.3.1.2. Oral Health Care
      • 12.3.1.3. Medicated Skin Care
      • 12.3.1.4. Wound Care
      • 12.3.1.5. Digestive Remedies
      • 12.3.1.6. Sleeping Aids
      • 12.3.1.7. Emergency Contraceptives
      • 12.3.1.8. Intimate Care
      • 12.3.1.9. Hair Care
      • 12.3.1.10. Cough Cold & Allergy Remedies
      • 12.3.1.11. Analgesics
      • 12.3.1.12. Dermatological
    • 12.3.2. Dietary Supplements
      • 12.3.2.1. Nutrition
      • 12.3.2.2. Vitamins
      • 12.3.2.3. Minerals
      • 12.3.2.4. Proteins
      • 12.3.2.5. Others
  • 12.4. Market Attractiveness Analysis By Product

13. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by End-user

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By End-user, 2015 - 2019
  • 13.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By End-user, 2020 - 2030
    • 13.3.1. 12-19 Years
    • 13.3.2. Male
    • 13.3.3. Female
    • 13.3.4. Kids
  • 13.4. Market Attractiveness Analysis By End-user

14. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Form Type

  • 14.1. Introduction / Key Findings
  • 14.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Form Type, 2015 - 2019
  • 14.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Form Type, 2020 - 2030
    • 14.3.1. Tablets
    • 14.3.2. Powders
    • 14.3.3. Liquids
    • 14.3.4. Others
  • 14.4. Market Attractiveness Analysis By Form Type

15. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Sales Channel

  • 15.1. Introduction / Key Findings
  • 15.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Sales Channel, 2015 - 2019
  • 15.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Sales Channel, 2020 - 2030
    • 15.3.1. Wholesalers & Distributors
    • 15.3.2. Pharmacy or Drug Stores
    • 15.3.3. Speciality Stores
    • 15.3.4. Online Retailers
    • 15.3.5. Hypermarkets/Supermarkets
    • 15.3.6. Other Sales Channel
  • 15.4. Market Attractiveness Analysis By Sales Channel

16. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Region, 2015 - 2019
  • 16.3. Current Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Region, 2020 - 2030
    • 16.3.1. North America
    • 16.3.2. Europe
    • 16.3.3. Middle East and Africa (MEA)
    • 16.3.4. East Asia
    • 16.3.5. South Asia
    • 16.3.6. Oceania
    • 16.3.7. Latin America
  • 16.4. Market Attractiveness Analysis By Region

17. North America OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 17.4.1. By Country
      • 17.4.1.1. U.S.
      • 17.4.1.2. Canada
    • 17.4.2. By Product
    • 17.4.3. By End-user
    • 17.4.4. By Form Type
    • 17.4.5. By Sales Channel
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product
    • 17.5.3. By End-user
    • 17.5.4. By Form Type
    • 17.5.5. By Sales Channel
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Latin America OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 18.4.1. By Country
      • 18.4.1.1. Brazil
      • 18.4.1.2. Mexico
      • 18.4.1.3. Rest of Latin America
    • 18.4.2. By Product
    • 18.4.3. By End-user
    • 18.4.4. By Form Type
    • 18.4.5. By Sales Channel
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product
    • 18.5.3. By End-user
    • 18.5.4. By Form Type
    • 18.5.5. By Sales Channel
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Europe OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 19.4.1. By Country
      • 19.4.1.1. Germany
      • 19.4.1.2. U.K.
      • 19.4.1.3. Spain
      • 19.4.1.4. France
      • 19.4.1.5. Italy
      • 19.4.1.6. Rest Of Europe
      • 19.4.1.7. Rest of Europe
    • 19.4.2. By Product
    • 19.4.3. By End-user
    • 19.4.4. By Form Type
    • 19.4.5. By Sales Channel
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Product
    • 19.5.3. By End-user
    • 19.5.4. By Form Type
    • 19.5.5. By Sales Channel
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. South Asia OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 20.4.1. By Country
      • 20.4.1.1. India
      • 20.4.1.2. Thailand
      • 20.4.1.3. Malaysia
      • 20.4.1.4. Indonesia
      • 20.4.1.5. Rest of South Asia
    • 20.4.2. By Product
    • 20.4.3. By End-user
    • 20.4.4. By Form Type
    • 20.4.5. By Sales Channel
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Product
    • 20.5.3. By End-user
    • 20.5.4. By Form Type
    • 20.5.5. By Sales Channel
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis

21. East Asia OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 21.1. Introduction
  • 21.2. Pricing Analysis
  • 21.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 21.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 21.4.1. By Country
      • 21.4.1.1. China
      • 21.4.1.2. Japan
      • 21.4.1.3. South Korea
    • 21.4.2. By Product
    • 21.4.3. By End-user
    • 21.4.4. By Form Type
    • 21.4.5. By Sales Channel
  • 21.5. Market Attractiveness Analysis
    • 21.5.1. By Country
    • 21.5.2. By Product
    • 21.5.3. By End-user
    • 21.5.4. By Form Type
    • 21.5.5. By Sales Channel
  • 21.6. Market Trends
  • 21.7. Key Market Participants - Intensity Mapping
  • 21.8. Drivers and Restraints - Impact Analysis

22. Oceania OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 22.1. Introduction
  • 22.2. Pricing Analysis
  • 22.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 22.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 22.4.1. By Country
      • 22.4.1.1. Australia
      • 22.4.1.2. New Zealand
    • 22.4.2. By Product
    • 22.4.3. By End-user
    • 22.4.4. By Form Type
    • 22.4.5. By Sales Channel
  • 22.5. Market Attractiveness Analysis
    • 22.5.1. By Country
    • 22.5.2. By Product
    • 22.5.3. By End-user
    • 22.5.4. By Form Type
    • 22.5.5. By Sales Channel
  • 22.6. Market Trends
  • 22.7. Key Market Participants - Intensity Mapping
  • 22.8. Drivers and Restraints - Impact Analysis

23. Middle East and Africa OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

  • 23.1. Introduction
  • 23.2. Pricing Analysis
  • 23.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 23.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 - 2030
    • 23.4.1. By Country
      • 23.4.1.1. GCC Countries
      • 23.4.1.2. Northern Africa
      • 23.4.1.3. South Africa
      • 23.4.1.4. Rest of MEA
    • 23.4.2. By Product
    • 23.4.3. By End-user
    • 23.4.4. By Form Type
    • 23.4.5. By Sales Channel
  • 23.5. Market Attractiveness Analysis
    • 23.5.1. By Country
    • 23.5.2. By Product
    • 23.5.3. By End-user
    • 23.5.4. By Form Type
    • 23.5.5. By Sales Channel
  • 23.6. Market Trends
  • 23.7. Key Market Participants - Intensity Mapping
  • 23.8. Drivers and Restraints - Impact Analysis

24. Market Structure Analysis

  • 24.1. Market Analysis by Tier of Companies (OTC Consumer Healthcare)
  • 24.2. Market Concentration
  • 24.3. Market Share Analysis of Top Players
  • 24.4. Market Presence Analysis
    • 24.4.1. By Regional footprint of Players
    • 24.4.2. Product foot print by Players
    • 24.4.3. Channel Foot Print by Players

25. Competition Analysis

  • 25.1. Competition Dashboard
  • 25.2. Pricing Analysis by Competition
  • 25.3. Competition Benchmarking
  • 25.4. Competition Deep Dive
    • 25.4.1. Sun Pharmaceutical Industries Limited
      • 25.4.1.1. Overview
      • 25.4.1.2. Product Portfolio
      • 25.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.1.4. Sales Footprint
      • 25.4.1.5. Strategy Overview
        • 25.4.1.5.1. Marketing Strategy
        • 25.4.1.5.2. Product Strategy
        • 25.4.1.5.3. Channel Strategy
    • 25.4.2. Glenmark Pharmaceuticals Ltd.
      • 25.4.2.1. Overview
      • 25.4.2.2. Product Portfolio
      • 25.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.2.4. Sales Footprint
      • 25.4.2.5. Strategy Overview
        • 25.4.2.5.1. Marketing Strategy
        • 25.4.2.5.2. Product Strategy
        • 25.4.2.5.3. Channel Strategy
    • 25.4.3. Johnson & Johnson Private Ltd, Pfizer, Inc.
      • 25.4.3.1. Overview
      • 25.4.3.2. Product Portfolio
      • 25.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.3.4. Sales Footprint
      • 25.4.3.5. Strategy Overview
        • 25.4.3.5.1. Marketing Strategy
        • 25.4.3.5.2. Product Strategy
        • 25.4.3.5.3. Channel Strategy
    • 25.4.4. American Health Corporation
      • 25.4.4.1. Overview
      • 25.4.4.2. Product Portfolio
      • 25.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.4.4. Sales Footprint
      • 25.4.4.5. Strategy Overview
        • 25.4.4.5.1. Marketing Strategy
        • 25.4.4.5.2. Product Strategy
        • 25.4.4.5.3. Channel Strategy
    • 25.4.5. Abbott Laboratories Inc.
      • 25.4.5.1. Overview
      • 25.4.5.2. Product Portfolio
      • 25.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.5.4. Sales Footprint
      • 25.4.5.5. Strategy Overview
        • 25.4.5.5.1. Marketing Strategy
        • 25.4.5.5.2. Product Strategy
        • 25.4.5.5.3. Channel Strategy
    • 25.4.6. GlaxoSmithKline plc
      • 25.4.6.1. Overview
      • 25.4.6.2. Product Portfolio
      • 25.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.6.4. Sales Footprint
      • 25.4.6.5. Strategy Overview
        • 25.4.6.5.1. Marketing Strategy
        • 25.4.6.5.2. Product Strategy
        • 25.4.6.5.3. Channel Strategy
    • 25.4.7. Sanofi S.A.
      • 25.4.7.1. Overview
      • 25.4.7.2. Product Portfolio
      • 25.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.7.4. Sales Footprint
      • 25.4.7.5. Strategy Overview
        • 25.4.7.5.1. Marketing Strategy
        • 25.4.7.5.2. Product Strategy
        • 25.4.7.5.3. Channel Strategy
    • 25.4.8. Piramal Enterprises Ltd.
      • 25.4.8.1. Overview
      • 25.4.8.2. Product Portfolio
      • 25.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.8.4. Sales Footprint
      • 25.4.8.5. Strategy Overview
        • 25.4.8.5.1. Marketing Strategy
        • 25.4.8.5.2. Product Strategy
        • 25.4.8.5.3. Channel Strategy
    • 25.4.9. Boehringer Ingelheim GmbH
      • 25.4.9.1. Overview
      • 25.4.9.2. Product Portfolio
      • 25.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.9.4. Sales Footprint
      • 25.4.9.5. Strategy Overview
        • 25.4.9.5.1. Marketing Strategy
        • 25.4.9.5.2. Product Strategy
        • 25.4.9.5.3. Channel Strategy
    • 25.4.10. Bayer AG
      • 25.4.10.1. Overview
      • 25.4.10.2. Product Portfolio
      • 25.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.10.4. Sales Footprint
      • 25.4.10.5. Strategy Overview
        • 25.4.10.5.1. Marketing Strategy
        • 25.4.10.5.2. Product Strategy
        • 25.4.10.5.3. Channel Strategy
    • 25.4.11. Teva Pharmaceutical Industries Ltd.
      • 25.4.11.1. Overview
      • 25.4.11.2. Product Portfolio
      • 25.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.11.4. Sales Footprint
      • 25.4.11.5. Strategy Overview
        • 25.4.11.5.1. Marketing Strategy
        • 25.4.11.5.2. Product Strategy
        • 25.4.11.5.3. Channel Strategy
    • 25.4.12. Ipsen SA, BASF SE
      • 25.4.12.1. Overview
      • 25.4.12.2. Product Portfolio
      • 25.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.12.4. Sales Footprint
      • 25.4.12.5. Strategy Overview
        • 25.4.12.5.1. Marketing Strategy
        • 25.4.12.5.2. Product Strategy
        • 25.4.12.5.3. Channel Strategy
    • 25.4.13. Koninklijke DSM N.V.
      • 25.4.13.1. Overview
      • 25.4.13.2. Product Portfolio
      • 25.4.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.13.4. Sales Footprint
      • 25.4.13.5. Strategy Overview
        • 25.4.13.5.1. Marketing Strategy
        • 25.4.13.5.2. Product Strategy
        • 25.4.13.5.3. Channel Strategy
    • 25.4.14. Reckitt Benckiser LLC.
      • 25.4.14.1. Overview
      • 25.4.14.2. Product Portfolio
      • 25.4.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.14.4. Sales Footprint
      • 25.4.14.5. Strategy Overview
        • 25.4.14.5.1. Marketing Strategy
        • 25.4.14.5.2. Product Strategy
        • 25.4.14.5.3. Channel Strategy
    • 25.4.15. Lonza Group Ltd.
      • 25.4.15.1. Overview
      • 25.4.15.2. Product Portfolio
      • 25.4.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.15.4. Sales Footprint
      • 25.4.15.5. Strategy Overview
        • 25.4.15.5.1. Marketing Strategy
        • 25.4.15.5.2. Product Strategy
        • 25.4.15.5.3. Channel Strategy
    • 25.4.16. Other Players (as per request)
      • 25.4.16.1. Overview
      • 25.4.16.2. Product Portfolio
      • 25.4.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 25.4.16.4. Sales Footprint
      • 25.4.16.5. Strategy Overview
        • 25.4.16.5.1. Marketing Strategy
        • 25.4.16.5.2. Product Strategy
        • 25.4.16.5.3. Channel Strategy

26. Assumptions and Acronyms Used

27. Research Methodology

List Of Tables

  • Table 1: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 2: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 3: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 4: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 5: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 6: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 7: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 8: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 9: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Region, 2015-2030
  • Table 10: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Region, 2015-2030
  • Table 11: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 12: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 13: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 14: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 15: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 16: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 17: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 18: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 19: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 20: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 21: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 22: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 23: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 24: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 25: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 26: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 27: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 28: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 29: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 30: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 31: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 32: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 33: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 34: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 35: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 36: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 37: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 38: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 39: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 40: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 41: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 42: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 43: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 44: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 45: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 46: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 47: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 48: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 49: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 50: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 51: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 52: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 53: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 54: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 55: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 56: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 57: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 58: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 59: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 60: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 61: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 62: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 63: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 64: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 65: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 66: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 67: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 68: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 69: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 70: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030
  • Table 71: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015-2030
  • Table 72: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015-2030
  • Table 73: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015-2030
  • Table 74: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015-2030
  • Table 75: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015-2030
  • Table 76: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015-2030
  • Table 77: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015-2030
  • Table 78: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015-2030
  • Table 79: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015-2030
  • Table 80: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015-2030

List of Figures

  • Figure 01: Global OTC Consumer Healthcare Market Value (US$ Mn) and Volume (Mn Tons) Analysis, 2015-2019
  • Figure 02: Global OTC Consumer Healthcare Market Value (US$ Mn) and Volume (Mn Tons) Forecast, 2020-2030
  • Figure 03: Global OTC Consumer Healthcare Market Value (US$ Mn), 2015-2019
  • Figure 04: Global OTC Consumer Healthcare Market Absolute $ Opportunity Value (US$ Mn), 2020-2030
  • Figure 05: Global OTC Consumer Healthcare Market Value (US$ Mn) Forecast, 2020-2030
  • Figure 06: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis by Product, 2015-2030
  • Figure 07: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis by Product, 2015-2030
  • Figure 08: Global OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 09: Global OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 10: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis by End-User, 2015-2030
  • Figure 11: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis by End-User, 2015-2030
  • Figure 12: Global OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 13: Global OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 14: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis by Form, 2015-2030
  • Figure 15: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis by Form, 2015-2030
  • Figure 16: Global OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 17: Global OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 18: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis by Sales Channel, 2015-2030
  • Figure 19: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis by Sales Channel, 2015-2030
  • Figure 20: Global OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 21: Global OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030
  • Figure 22: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis by Region, 2015-2030
  • Figure 23: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis by Region, 2015-2030
  • Figure 24: Global OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Region, 2020-2030
  • Figure 25: Global OTC Consumer Healthcare Market Attractiveness by Region, 2020-2030
  • Figure 26: North America OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 27: North America OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 28: North America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 29: North America OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 30: North America OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 31: North America OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 32: North America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 33: North America OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 34: North America OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 35: North America OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 36: North America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 37: North America OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 38: North America OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 39: North America OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 40: North America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 41: North America OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 42: North America OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 43: North America OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 44: North America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 45: North America OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030
  • Figure 46: Latin America OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 47: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 48: Latin America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 49: Latin America OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 50: Latin America OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 51: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 52: Latin America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 53: Latin America OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 54: Latin America OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 55: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 56: Latin America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 57: Latin America OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 58: Latin America OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 59: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 60: Latin America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 61: Latin America OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 62: Latin America OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 63: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 64: Latin America OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 65: Latin America OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030
  • Figure 66: Europe OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 67: Europe OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 68: Europe OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 69: Europe OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 70: Europe OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 71: Europe OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 72: Europe OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 73: Europe OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 74: Europe OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 75: Europe OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 76: Europe OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 77: Europe OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 78: Europe OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 79: Europe OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 80: Europe OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 81: Europe OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 82: Europe OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 83: Europe OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 84: Europe OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 85: Europe OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030
  • Figure 86: South Asia OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 87: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 88: South Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 89: South Asia OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 90: South Asia OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 91: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 92: South Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 93: South Asia OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 94: South Asia OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 95: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 96: South Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 97: South Asia OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 98: South Asia OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 99: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 100: South Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 101: South Asia OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 102: South Asia OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 103: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 104: South Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 105: South Asia OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030
  • Figure 106: East Asia OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 107: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 108: East Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 109: East Asia OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 110: East Asia OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 111: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 112: East Asia OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 113: East Asia OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 114: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 115: East Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 116: East Asia OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 117: East Asia OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 118: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 119: East Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 120: East Asia OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 121: East Asia OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 122: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 123: East Asia OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 124: East Asia OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030
  • Figure 125: Oceania OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 126: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 127: Oceania OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 128: Oceania OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 129: Oceania OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 130: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 131: Oceania OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 132: Oceania OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 133: Oceania OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 134: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 135: Oceania OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 136: Oceania OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 137: Oceania OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 138: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 139: Oceania OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 140: Oceania OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 141: Oceania OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 142: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 143: Oceania OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 145: MEA OTC Consumer Healthcare Market Value (US$ Mn) by Country, 2015-2030
  • Figure 146: MEA OTC Consumer Healthcare Market Volume (Mn Tons) by Country, 2015-2030
  • Figure 147: MEA OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Country, 2020-2030
  • Figure 148: MEA OTC Consumer Healthcare Market Attractiveness by Country, 2020-2030
  • Figure 149: MEA OTC Consumer Healthcare Market Value (US$ Mn) by Product, 2015-2030
  • Figure 150: MEA OTC Consumer Healthcare Market Volume (Mn Tons) by Product, 2015-2030
  • Figure 151: MEA OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Product, 2020-2030
  • Figure 152: MEA OTC Consumer Healthcare Market Attractiveness by Product, 2020-2030
  • Figure 153: MEA OTC Consumer Healthcare Market Value (US$ Mn) by End-User, 2015-2030
  • Figure 154: MEA OTC Consumer Healthcare Market Volume (Mn Tons) by End-User, 2015-2030
  • Figure 155: MEA OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By End-User, 2020-2030
  • Figure 156: MEA OTC Consumer Healthcare Market Attractiveness by End-User, 2020-2030
  • Figure 157: MEA OTC Consumer Healthcare Market Value (US$ Mn) by Form, 2015-2030
  • Figure 158: MEA OTC Consumer Healthcare Market Volume (Mn Tons) by Form, 2015-2030
  • Figure 159: MEA OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Form, 2020-2030
  • Figure 160: MEA OTC Consumer Healthcare Market Attractiveness by Form, 2020-2030
  • Figure 161: MEA OTC Consumer Healthcare Market Value (US$ Mn) by Sales Channel, 2015-2030
  • Figure 162: MEA OTC Consumer Healthcare Market Volume (Mn Tons) by Sales Channel, 2015-2030
  • Figure 163: MEA OTC Consumer Healthcare Market Y-o-Y Growth (%) Projections, By Sales Channel, 2020-2030
  • Figure 164: MEA OTC Consumer Healthcare Market Attractiveness by Sales Channel, 2020-2030